Brief: Enorama Pharma Q1 Operating Loss Widens To SEK 3.0 Million
May 16 (Reuters) - ENORAMA PHARMA AB ERMA.ST :
* Q1 OPERATING LOSS SEK 3.0 MILLION VERSUS LOSS SEK 1.5
MILLION
YEAR AGO
* Q1 NET SALES SEK 1.6 MILLION VERSUS SEK 0 MILLION YEAR AGO
Source text for Eikon: ID:nWkr1Jjs71
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO